Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Spain

Marie Skłodowska-Curie Action · Running

AiRPaDD Advancing Reaction Platforms for Drug Discovery

Coordinator
Universidad Del Pais Vasco/ Euskal Herriko Unibertsitatea, Spain
Runs
1 February 2023 to 31 January 2027
Status
Running
EU funding
€799k
Total cost
—
Partners
5 organisations in 4 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101069949

What the project is doing

In the project's own words, from its summary on CORDIS.

This Action will contribute to the sustainable development of European chemical industries in the coming decades by delivering an ambitious doctoral training programme that draws on expertise from industry and academia across 4 European countries. The research agenda and experiential training will grow the skills base beyond approaches that have relied upon a limited set of molecular scaffolds and a relatively small sub-set of reactions to exploit new reaction paradigms and platforms (e.g. high throughput experimentation, photoredox & electrochemistry) that meet the needs of modern drug discovery science.

Topics

Who is involved

OrganisationCityCountryRole
Universidad Del Pais Vasco/ Euskal Herriko UnibertsitateaLeioaSpainCoordinator
Sanofi-Aventis Deutschland GmbHFrankfurt Am MainGermanyParticipant
Astrazeneca ABSodertaeljeSwedenParticipant
AF ChemPharm LtdSheffieldUnited KingdomAssociatedpartner
The University of SheffieldSheffieldUnited KingdomAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI